METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND

• 收藏
• 分享

专利权人:

ENDOCYTE; INC.

发明人:

Christopher Paul LEAMON,Binh NGUYEN

申请号：

US15554866

公开号：

US20180036364A1

申请日:

2016.03.01

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating PSMA expressing cancers with a PSMA ligand-tubulysin compound. The invention described herein also relates to methods of treating PSMA-expressing cancers with a PSMA ligand-tubulysin compound in patients where stable disease results after treatment with the PSMA ligand-tubulysin compound.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/